Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.210
-0.010 (-0.45%)
At close: May 22, 2026, 4:00 PM EDT
2.250
+0.040 (1.81%)
After-hours: May 22, 2026, 7:52 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $8.14 million as of May 22, 2026. Its market cap has increased by 159.22% in one year.
Market Cap
8.14M
Enterprise Value
3.23M
1-Year Change
159.22%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $8.14M, a decrease of -99.99%. That is a compound annual growth rate of -83.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 8.14M | 119.04% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 8.84M |
| Imunon | 8.76M |
| PharmaCyte Biotech | 8.70M |
| Quoin Pharmaceuticals | 8.60M |
| Genprex | 8.55M |
| NuCana | 8.41M |
| PMGC Holdings | 8.09M |
| CNS Pharmaceuticals | 7.92M |